Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical & Experimental Allergy

Topics

Medicine

Immunology

Pathology

Physiology

Internal Medicine

Show all topics

DOI

10.1111/cea.12400

License

CC-BY-NC-ND

Other Formats

PDF